MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSM
Project Number4UH3AI169658-03
Former Number4UG3AI169658-03
Contact PI/Project LeaderSCHNALL, REBECCA Other PIs
Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
PROJECT SUMMARY
There is a critical need to better understand the epidemiology of HIV acquisition in the United States (US),
particularly among cisgender gay, bisexual and other men who have sex with men (MSM), one of the key
populations essential to target for End the HIV Epidemic (EHE) initiatives. In direct response to RFA-AI-21-018,
this study will use innovative technology to recruit and retain a large cohort of high-risk, HIV-negative young
men who have sex with men (YMSM) focusing on racial/ethnic minority YMSM and high HIV prevalence
geographic areas (known as “hot spots”). Furthermore, we will leverage this cohort to conduct a large-scale
clinical trial while maintaining the standard of care control arm as a longitudinal observational cohort for
epidemiologic analyses. Our study team is uniquely positioned and has all the relevant expertise to conduct
this study having successfully recruited and retained more than 12,000 YMSM in a full range of research
studies across the HIV continuum (e.g., epidemiology, intervention development, mHealth, PrEP, clinical trials,
innovative geospatial methods). We have had specific success conducting prevention research with YMSM
(17-25 years), including racially and ethnically diverse YMSM, our target demographic group. Further, we have
previously leveraged advanced social media advertising techniques and used innovative geospatial analytics
to target/study “communities within communities”, reaching hard-to-reach YMSM from diverse geographic
areas (e.g., rural zip codes, U.S. tribal lands, etc.) and young ages (e.g., YMSM 13-18 years of age). We will
harness innovative technology to recruit, during 36-months of enrollment, and then retain a large cohort (N =
5,000) of 17-25 year old YMSM, the majority being Black and Latino, who are at high-risk of HIV transmission
(e.g., history of condomless anal sex) and follow them every 6 months thereafter. We will conduct an entirely
virtual, digital clinical trial (Specific Aim #1) testing whether MyPEEPS Mobile (an evidence-based mHealth HIV
prevention intervention) reduces HIV incidence among HIV-negative YMSM (17-25 years old) looking at the
influence of theory-driven social, ecological, and geospatial factors on intervention uptake and efficacy
inclusive of measures that align with traditional models of behavior change such as the Information Motivation
Behavior Model. A social-ecological theoretical framework will also guide the analysis of the longitudinal
observational cohort study (Specific Aim #2) of the 2,500 control arm participants to assess individual, network,
geospatial, and public policy correlates of HIV risk and health seeking behaviors (e.g., PrEP uptake) comparing
individuals who become HIV-positive to those who do not. Intervention Implications. The findings from this
research will have important real-world implications for research and practice. For example, understanding how
individual, network, geospatial, and public policy factors correlate with HIV incidence and moderate
intervention effects will help inform how and where interventions should be delivered.
Public Health Relevance Statement
PROJECT NARRATIVE
Addressing the End the HIV Epidemic initiatives, this study will use innovative electronic methods (e.g., social
media with community informed advertisements) to recruit and retain a large (N=5,000), diverse national
sample of high-risk young men who have sex with men (YMSM) 17-25 years of age to better understand
correlates of HIV-related sexualrisk and HIV incidence within the context of a theoretically-grounded social-
ecological framework. In addition to the epidemiologic aim of the proposed research, we will test the efficacy of
MyPEEPS Mobile, a promising mHealth HIV prevention intervention in reducing HIV incidence among YMSM.
NIH Spending Category
No NIH Spending Category available.
Project Terms
18 year oldAIDS preventionAccountingAddressAdvertisementsAdvertisingAffectAgeAge YearsAlcohol consumptionAnxietyBehaviorBehavioral ModelBisexualBlack raceClinical TrialsCommunitiesCrimeDataDiscriminationElectronicsEnrollmentEpidemicEpidemiologyEthnic OriginEvidence based interventionExclusionFacebookFrequenciesFundingFutureGaysGeographic LocationsHIVHIV InfectionsHIV SeronegativityHIV SeropositivityHIV diagnosisHIV riskHot SpotIncidenceIndividualIndividual DifferencesInstagramInstitutionInterventionIntervention StudiesKnowledgeLatinoLiteratureMeasuresMediatorMental DepressionMethodsModelingMotivationNeighborhoodsOutcomeParticipantPersonsPhasePoliciesPopulationPositioning AttributePovertyPredispositionPrevalencePrevention ResearchPrincipal InvestigatorPublic PolicyRaceRandomizedRecording of previous eventsReportingResearchResearch DesignResearch PersonnelRiskRuralSample SizeSamplingScienceSelf EfficacySocial supportTechniquesTestingTikTokTimeTreatment EfficacyTwitterUnited StatesUnited States National Institutes of HealthUnsafe Sexarmbehavior changecisgendercohortcondomless anal sexdigitaldigital deliveryefficacy evaluationefficacy testingefficacy trialepidemiology studyethnic diversityethnic minorityevidence baseexperiencehealth care servicehealth seeking behaviorhigh riskinnovationinnovative technologiesintervention effectintimate partner violencelongitudinal analysismHealthmalemen who have sex with menobservational cohort studypeerpre-exposure prophylaxispreventive interventionracial diversityracial minorityrecruitresearch studyresponseretention ratesame-sex partnershipseroconversionsexual minoritysexualriskbehaviorsexualrisk reductionsocialsocial mediasocial stigmastandard of caresubstance usesuccesstheoriestherapy developmenttransmission processtribal landsuptakevirtualyoung men who have sex with men
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
01-September-2022
Project End Date
21-March-2025
Budget Start Date
01-August-2024
Budget End Date
21-March-2025
Project Funding Information for 2024
Total Funding
$2,497,744
Direct Costs
$2,615,064
Indirect Costs
$1,015,363
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$2,497,744
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 4UH3AI169658-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 4UH3AI169658-03
Patents
No Patents information available for 4UH3AI169658-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 4UH3AI169658-03
Clinical Studies
No Clinical Studies information available for 4UH3AI169658-03
News and More
Related News Releases
No news release information available for 4UH3AI169658-03
History
No Historical information available for 4UH3AI169658-03
Similar Projects
No Similar Projects information available for 4UH3AI169658-03